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I  _  _  -
I It is becoming increasingly evident that hormones exert
their regulatory effects on tissues and organs by affecting 
rates of enzymatic processes. Although the effect of hormonejs 
pn the body, even in minute quantities, is usually marked, 
the precise chemical functions of the various hormones 
remained totally obscure until the concept of hormone-enzyme 
Lnter-relationships was derived. With this concept as a 
working hypothesis such progress has been made in the last 
ten years that it is now possible to give many examples of 
enzyme systems which are influenced by endocrine substances. 
Several recent reviews, Dorfman (1952), Lieberman (1953), 
Porter (1954), Verzar (1952), serve admirably in this manner.
Investigators in this field seem to agree that hormones 
nay exert their influence on enzymes in one of four possible 
ways: (l) by changes in enzyme concentrations in the tissues
(2) by the hormone functioning as a component of an enzyme 
system, (3) by the hormone accelerating or inhibiting an
enzyme system, or (4) by direct or indirect effects on 
accelerators and/or inhibitors of enzyme systems.
With this concept of hormonal regulation of enzyme 
activity in mind the present study was undertaken in an 
attempt to determine whether the enzyme catalase is affected 
by endocrine substances. The physiological role of catalase 
has not been fully clarified and it was felt that if some of 
the factors that influence its activity were better known 
perhaps its physiological function could more readily be 
understood.
Until recently it was believed that the function of 
catalase was only a protective one against the toxic effect 
of hydrogen peroxide by promoting the degradation of hydrogen 
peroxide to water and oxygen. Keilin and Hartree (1954), 
however, have shown that catalase may in addition function 
in coupled oxidations. They observed the oxidation of 
alcohols to aldehydes in the presence of catalase and 
hydrogen peroxide slowly generated by chemical reactions 
or furnished by the action of an enzyme such as xanthine 
oxidase. Methanol, ethanol, N-propanol, isobutanol, and 
sthylene glycol were shown to undergo oxidation in this 
system. From this study Keilin and Hartree concluded that 
although catalase does promote the decomposition of hydrogen 
peroxide into water and molecular oxygen, thereby protecting 
cells from the toxic effects of hydrogen peroxide, the
catalysis of coupled oxidations by means of hydrogen peroxide 
formed in a primary oxidation is the most important biological 
property of catalase. Theorell (1951) and Chance (l95l) are 
also of the opinion that the chief physiological function of 
catalase is its ability to catalyze coupled oxidations.
iThe mechanism of action of catalase can be more readily 
understood if it is described in the form of equations. Thus 
according to the old theory of its action the enzyme (E) com­
bined with the substrate (S), which is hydrogen peroxide^ to 
give an enzyme-substrate complex (ES). This complex then 
breaks down spontaneously to give the enzyme plus products 
(P).
E + S--------- rE8 (Equation I)
ES---------------Æ  •*- P
Due largely to the work of Britten Chance (1951), the con­
secutive reaction theory for catalase is now the generally
accepted mechanism for its action.
E---+- S-------- rES (Equation II)
ES +■ S-------- Æ  4- P
Here a hydrogen peroxide molecule (S), which is the specific 
substrate for catalase, reacts with catalase (E) to form the
enzyme-substrate complex (ES); an additional molecule of
hydrogen peroxide then reacts with the enzyme-substrate com— 
pl-ex—to—g-iv-e—ih-e—e-n-zyme—plus—products— (.P-)-,—w-hi-c-h—are—wat-er--
and oxygen in this case. This theory of two consecutive 
bimolecular reactions (Equation II) is in contrast to the 
older idea that the activity of catalase could be described
I
iby a single bimolecular reaction followed by a spontaneous 
[inonomolecular reaction (Equation I). The question then arises 
|as to how the reaction of Equation II can account for the
icoupled oxidation reactions in which catalase is known to 
.participate. Equation II can be written in a more general 
form that will allow explanation of both properties of 
catalase, i.e., the coupled oxidation reaction and the simple 
decomposition of hydrogen peroxide.
E + S- 'ES
(Equation III)
ES + -rB +- SHg A
Here AH2 represents a hydrogen donor molecule which may be 
an alcohol. Using ethyl alcohol as an example to demonstrate 
a coupled oxidation reaction, the equation would be
E +- H202*̂ -----TE-H2O2 (Equation IV)
1-E + 2 H2O + CH3CH«0
In the case of the simple decomposition of hydrogen peroxide, 
a second hydrogen peroxide molecule would serve as the hydrog 
donor and react with the catalase-hydrogen peroxide complex 
in this manner:
E + H2O2"'— — PE-H2O2 (Equation V)
__________ E-H2O2 ^2^2^' — ■*- 2 H2G —t:__0_2__________________
en
From this it is clear that the consecutive reaction theory 
accounts for both observed actions of catalase, i.e., the 
decomposition of hydrogen peroxide to water and oxygen and 
the function of catalase in coupled oxidations.
-One further interesting aspect of the coupled oxidation 
iaction of catalase arises from the recent work of Tauber 1 
(1954). He demonstrated that dilute solutions of crystalline 
catalase, in the presence of hydrogen peroxide, can oxidize 
'a variety of large molecules by coupled oxidation. Thus, 
alpha-naphthol and p-phenylenediamine are oxidized to indo- ! 
phenol purple; p-aminobenzoic acid, sulfathiazole, adrenalinj, 
ephedrine sulfate and tyrosine are coupled with catechol by 
oxidation to form colored compounds. Pyrogallol is oxidized 
to the insoluble end product purpurogallin and catechol is 
oxidized to soluble products of different colors. This work 
suggests another important role of catalase since numerous 
complex compounds found in nature can be derived from simple 
phenols and phenol derivatives by oxidative coupling.
Investigators in the field of cancer have for many 
years had an interest in the relationship between catalase 
activity and malignant growths. In the early years of this 
century Rosenthal (1912), working with mice, and Brahn (1916), 
studying cancerous tissues of man, came to the conclusion that 
liver catalase activity is depressed by malignant growths.
It was not, however, until 1941 that active interest in this
subject was revived, largely through the work of Greenstein 
and his co-workers. Their findings have recently been 
summarized (Greenstein, 1947) and show the following facts:
1. The decrease of liver catalase is progressive with 
the growth of the tumor and is most marked in animals 
bearing rapidly growing tumors.
2. The effect is reversible, i.e., the liver catalase 
activity returns to normal after excision or spon­
taneous regression of the tumor. This return to a 
normal level is rapid, often seen within 24 to 48
hours after removal of the tumor.
3. Of the other liver enzymes studied in tumor-bearing 
rats, only arginase showed any decrease in activity. 
The reduction in activity of this enzyme was much
less striking than that of catalase.
4. Kidney catalase activity is depressed much less than 
that of liver; only in mice with spontaneous mammary 
tumors is it lowered as much as, or more than, liver 
catalase.
5. The depression of liver catalase is not due simply to 
the presence of growing tissue, since pregnancy or 
growing implants of embryonic tissue fail to affect
it.
Investigators, assuming that the nutritional state of
e the important factor involved in
I the lowering of catalase activity have made numerous attempts
I  '  '  '  '
I  to influence the liver catalase of normal animals by diet.
j  . . .  ■ . .  .
jGreenstein (1941) found that a 3-day fast had no effect on 
'liver catalase activity of rats. Weil-Malherbe (1948) 
reported that the catalase activity of normal rat liver was
|not significantly changed by a high (45# casein) or a low
j
I(18# casein) protein diet, 
j Although it is a well established phenomenon of cancer,
' Ithe mechanism by which a distant tumor affects liver catalase 
remains unknown. Of the several hypotheses proposed, the 
one that seems to have the strongest experimental support 
suggests that the effect is produced by one or more substances 
elaborated by the cancer cells and released into the blood 
stream. Nakahara and Fukuoka (1949) have reported the 
isolation of a proteose-like material from human cancers 
which, when injected intraperitoneally into mice, produces a 
marked diminution in liver catalase. This fraction is water 
soluble and alcohol insoluble; it could not be isolated from 
normal tissue, even that adjacent to the tumor, and it had 
no effect in vitro on homogenates of normal liver. Greenfield 
and Meister (1951), Adams (1950), and Appleman (1950) have 
confirmed these findings with experimental tumors and have 
succeeded in concentrating the •'anti—catalase fraction.
The preparation of Greenfield and Meister caused a significant
8
j  drop in liver catalase activity within 12 hours after it was 
I  injected intraperitoneally into mice. At 24 hours after 
I inject ion of the preparation catalase activity was lowered 
|by more than 50^ and after 72 hours the activity was back 
within normal limits. The depression of liver catalase 
^activity was not accompanied by a significant decrease in 
‘liver lactic dehydrogenase, dehydropeptidase, and glutamic- 
jalanine transaminase. The activity of the tumor fractions 
was not affected by digestion with 6 N HCL for 4& hours.
CHAPTER II 
EXPERIMENTAL PROCEDURE
Albino rats of the Holtzman strain were used as experi­
mental animals throughout this study. In order to minimize 
the variability between groups of animals, each experiment 
was carefully controlled by using animals of the same age anii 
sex. Determined values of catalase activity of the livers of 
experimental and untreated animals were compared. Data so 
derived, as set forth in the various tables to follow, were 
treated statistically and the probability established.
Catalase activity was measured by the method of 
Feinstein (1949)* This method consists of the use of sodium 
perborate as the substrate and of the determination of the 
perborate remaining after catalase action by titration with
potassium permanganate.
The livers were removed from the animals under light 
ether anesthesia and were immediately placed in cold phosphate 
buffer (M/15s pH 6.8) to remove the excess blood. The tissuî 
was then blotted dry, placed in a glass container and immedi­
ately frozen in a deep freeze unit. In earlier experiments
10
(Troop, 1953, unpublished thesis) we found that freezing of 
rat liver at —18 degrees G., for periods as long as 12 days 
had no apparent effect on the catalase activity.
After being frozen for at least one day but never 
longer than three days, a sample was taken from each lobe of 
Ithe liver. The samples from any one liver were combined, 
^weighed and finally homogenized in ten times their weight of 
;ice-cold phosphate buffer (M/l5; pH 6.8) for one minute in a 
faring blendor with a micro-attachment. A one ml. sample of 
the homogenate was then diluted 1:50 with triple distilled 
water giving a final dilution of 1:500, and the catalase 
activity determined.
The substrate, as mentioned above, was 1.5$ sodium 
perborate, tetrahydrated, adjusted to pH 6.8 with concen­
trated HCl. Eight ml. of substrate and 1.5 ml. of phosphate 
buffer (M/15; pH 6.8) were placed in a series of four 125 ml. 
Erlenmeyer flasks. The flasks were covered with watch-glasses 
and immersed in a bath at 37 degrees C. for exactly 15 minut€is 
after which 0.5 ml. of water was added to the first flask,
0.5 ml. of the tissue homogenate to the next two flasks 
(giving duplicate determinations for each animal), and 0.5 
ml. of water to the fourth flask. After exactly 5 minutes of 
incubation, 10 ml, of 2 N sulfuric acid were added to each 
flask to stop the enzyme action. The contents of the flasks
11
were then titrated irith standard potassium permanganate. This 
titres of the first and fourth flasks, containing perborate 
land buffer as in the test flasks, but with water replacing 
the homogenate, were used as base points from which to cal­
culate the perborate destroyed by the enzyme. At various
itimes throughout this study the permanganate reducing capacity
I ■■ '
Iof liver tissue itself was determined. For this purpose an 
jadditional flask was used containing tissue (1î500 dilution) 
jand buffer but with water replacing perborate. At no time i 
was the liver tissue factor alone great enough to register on 
the micro-pipette used for titration.
The enzyme activity was expressed as milliequivalents 
of sodium perborate destroyed per gram, wet weight, of tissue 
under the conditions specified above.
Cortisone was the first synthetic steroid studied for 
its effect on liver catalase in the intact rat. Table I 
presents the data obtained from 24 rats. The animals were 
divided into four groups, each containing 6 rats. Group 1 
was maintained as controls, receiving no treatment. The 
animals in group 2 were injected with 2 mgm. of cortisone 
acetate subcutaneously each day for 15 days before being 
sacrificed and their livers removed and assayed for catalase 
activity. Those in group 3 received 5 mgm. of cortisone 
acetate each day for 17 days and the ones in group 4 were
-f-or—l-5—<iays-.----------------------------
TABLE I
































* millieqnivalents of sodium, perborate destroyed per gram of tissue, 
** significant at .1$ level of probability.
H10
This table vras reproduced from'Masters Thesis; The Effect of Cortisone on Rat Livér 
Catalase Activity. R, C. Troop, University of Oklahoma, School of Medicine, 1953.
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The catalase activity of the liver was found to
decrease progressively as the dosage of cortisone was increased,
. - ■ I
jDoses of 2 mgm. gave a 26$ depression, 5 mgm. a 41$ depression, 
jand finally the 10 mgm. dosage gave a 50$ depression. The 
increase in dosage also caused a decrease in both adrenal 
weight and body weight.
  ,
After observing this marked response to cortisone, it
was decided to study the effect of adrenocorticotropic hormone
(ACTH) on this enzyme system. Two experimental groups of
animals were used (Table II). One group was given 2 mgm. of
ACTH^ per day, subcutaneously, for 12 days and the other
group was injected with 5 mgm. of ACTH daily for 14 days.
The results were negative in that neither of the treated
groups showed a significant difference from the control group.
It must be pointed out, however, that data derived from the
group receiving 5 mgm. of ACTH each day were on the borderline
of statistical significance, indicating that a series of
animals receiving higher doses of ACTH might yield data which
would be significantly different. As will be shown later,
this experiment has now been repeated with larger groups of
animals and higher doses of ACTH, but at no time have we
observed a depression of catalase activity with ACTH. This
lArmour's ACTH, lyophilized. Standard LA-l-A. This 

































This table was reproduced from Masters Thesis: The Effect of Cortisone on Rat Liver
Catalase Activity. R. C. Troop, University of Oklahoma, School of Medicine, 1953.
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interesting difference between the action of cortisone and 
ACTH will be discussed later.
The influence of ACTH on liver catalase activity was 
studied further in four additional groups of rats (Table III), 
The animals in groups 1 and 2 were females; those in group 
two received lyophilized ACTH (Armour's) in saline at the 
rate of 2 mg. daily for 6 days. The liver catalase activity 
did not differ significantly from that of the untreated 
female controls. The animals in groups 3 and 4 were males. 
Group three was maintained as controls and group 4 was given 
ACTH in a gel preparationl. Six units (l unit equivalent to 
one mgm.) were injected subcutaneously daily for six days.
Here again there was no difference in catalase activity 
between treated and control animals, indicating that ACTH 
does not depress the liver catalase activity in the rat. The 
enlargement of the adrenals in the treated animals in groups 
2 and 4 indicated that a systemic response was elicited from 
the ACTH.
Comparison of groups 1 (female controls) and 3 (male 
controls) of Table III gives a definite indication of a sex 
difference in liver catalase activity; the males having much 
the higher value. Because of the possible importance of a 
sex difference in the hormonal control of catalase activity.
^Courtesy of Dr. S. L. Steelman, Armour Laboratories, 
jte-seaj^ch. Pepar-tiaent-,— Chijcag.o_,— HJL,— (Long-Acting HP ACTHAR, Gej.)
TABLE III







Body Wt. Activity Range
1 CONTROLS
(females)





5 32.6 465* (418-499)
3 CONTROLS(maies)
8 18.7 +50 gm 967 (850-1077)
4 ACTH-gel 
(maies,
6 units/ * 
day; 10 
days)
8 22.5 +29 957* (818-1076)




[this point was investigated further. Fifteen untreated rats 
|of the same age were used. Eight of the animals were males 
■and seven of them were females. Table 17 shows that the liver
I
catalase activity of the male rat is approximately 2.5% greater 
than the corresponding activity of the female.
TABLE 17
SEX DIFFERENCE IN LI7EB CATALASE ACTI7ITT 
Number of
Sex Animals Activity Range
MALES 8 967 (850-1077)
FEMALES 7 752 (644-834)
A sex difference in catalase activity of the livers oi 
animals has been noted by other investigators. Adams (1950) 
found the liver catalase activity in the male mouse to be 
from 20 to 30 percent higher than in the female mouse. Schuljtze 
and Kuiken (1941) noted a greater liver catalase activity in 
aale rats than in female rats but their experiments were not 
controlled in a manner that will allow a quantitative value 
bo be given for the difference.
, . . . . . . . . .
With this sex difference in view, it was of immediate
interest to determine whether catalase activity could be 
quantitatively affected by appropriate sex hormone admini­
stration. To this end a number of female rats were given 
testosterone as shown in Table 7. The animals in groups 1
£— î aee-ived.-----
UNIVERSITY OF OKLAHOMA 
LIBRARY.
TABLE ?




















3 166 d. CONTROLS 7 27.2 mg +7 636 (516-742)




Ô 22.1 +11 727** (683-826)
5 79 d. CONTROLS 7 28.9 +36 752 (644—834)
6 79 d. TESTOSTERONE (5mg/dayj 11 
days, intra­
muscularly)
8 19.9 +27 (649-828)
* significant at level of probability.
** significant at 5^ level of probability.
*** not significant at level of probability.
H0)
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testosterone!, 5 mgm. daily subcutaneously for 10 days, after 
which the livers were removed and assayed for catalase activ­
ity. The treated animals had a significantly higher liver 
catalase activity than the controls. The significance of the 
difference between the means of these two groups was at the 
1% level of probability.
The animals in groups 3 and 4 were also mature females. 
The rats in group 4 received implants of two 20 mgm. testos­
terone pellets^ subcutaneously 12 days before the liver was 
excised for assay of its catalase activity. It was calculated 
that approximately 0.6 mgm. of the implanted material was 
absorbed per day. Here again the testosterone treated animals 
had greater liver catalase activity than did their controls. 
The difference is not so great as in groups 1 and 2 but it is 
statistically acceptable at the level of probability.
Finally, the immature female rats in groups 5 and 6 
were studied. The animals in group 6 were injected^ intra­
muscularly with 5 mgm. of testosterone^» daily for a period o:* 
11 days. The difference in the liver catalase activity of 
these two groups was not statistically significant. This 
immediately raises a question as to why testosterone failed 
to raise the catalase activity in this group (group 6) as it
iRepositol Testosterone, Pitman-Moore Go.
2oreton-F Pellets, Courtesy of Dr. E. Henderson, Sobering 
Corporation, Bloomfield, New Jersey.
______ 3oreton-F, Aqueous Suspension of testosterone IJ.SiP.
Courtesy of Dr. E. Henderson, Cohering Corporation.
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did in groups 2 and 4. Possible reasons for this difference 
will be discussed later.
I Since testosterone promotes an increase in catalase
I  activity when administered to the mature female rat, it was 
jfelt that castration of the male animal might reduce this 
enzyme activity. Accordingly a group of 8 male rats was 
castrated and the catalase activity of their livers was com­
pared With that of the livers of 7 control animals. Table VI 
shows the results of this procedure. The operated animals 
were castrated via the abdominal approach ten days before 
they and tfi eir controls were sacrificed and analyzed for 
enzyme activity. Although the average catalase value for the 
castrated group was slightly higher than for the control group 
the difference did not stand when, the data were statistically 
analyzed.
Effect of Hydrocortisone on Liver Catalase Activity
When hydrocortisone became available to us, its influ­
ence on catalase activity was tested. This compound, unlike 
cortisone, is considered to be a true secretory product of tljie 
adrenal cortex (Hechter and Pincus, 1954)* Hydrocortisone^ 
was administered by stomach tube at the rate of 5 mgm. per d^y 
for 10 days. The recent work of Hyde (1954) has shown that
^Hydrocortone Acetate, saline suspension. Sharp and Dolime 
Courtesy Dr. Elmer Alpert, Merck and Co., Rahway, Hew Jersey,,
TABLE VI
EFFECT OF CASTRATION ON LIVER CATALASE ACTIVITY IN MALE RATS 
Condition Number of Change in Adrenal
of Animals Animals Body Wt. Weight Activity Range
CONTROLS 7 +12 gm 20.2 mg 712 (602-813)
CASTRATED 8 -23 20.7 655* (576-755)
^ not significant at 5% level of probability.
H
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hydrocortisone is almost completely absorbed from the gastroi- 
I intestinal tract when given in this manner. That good absorp­
tion occurred in this experiment (Table VII) is indicated by 
the sharp reduction in adrenal weight of the animals given 
: hydrocortisone. The catalase activity was depressed 32% in 
I  the treated animals making it apparent that hydrocortisone 
I acts similarly to cortisone with respect to catalase activity.
I
I TABLE VII
I LIVER CATALASE ACTIVITY AFTER HYDROCORTISONE TREATMENT
Number of Adrenal Change in 
Treatment Animals Weight Body Wt. Activity Range
CONTROLS 8 18.1 mg +50 gm 96? (850-1077)
HYDROCORTISONE - '
(5mg/dayg 8 11.6 -2 654 (441-865)
10 days)
^ significant at 1% level of probability.
Effect of Adrenalectomy on Liver Catalase Activity 
It might be inferred that since cortical hormones 
cause a depression of catalase activity, adrenalectomy would 
promote an increase in this enzyme. To test this assumption 
the work in Table VIII was carried out. These animals were 
males, 77 days old.
The operated group was adrenalectomized 12 days before 
autopsy and maintained on dry sodium chloride ^  lib. There 
was no difference in catalase activity of the two groups.
23
, TABLE VIII
I EFFECT OF ADRENALECTOMY ON LIVER CATALASE ACTIVITY 
Condition Number of Change in
i  of--Animals Animals Body Wt. Activity Range
I CONTROLS 8 ■•‘50 gm 967 (850-1077)
I ADRENALECTOMIZED 6 -̂ 31 94S (896-1058)
I  Effect of Hypophyseetomy and Growth Hormone
on Catalase Activity
1 'In 1951 Gaebler and Mathies studied liver catalase
activity in hypophysectomized rats. They found a marked 
increase in catalase activity in female rats after removal 
of the pituitary. Small doses of growth hormone did not 
lower the high catalase activity of these operated animals 
but large doses reduced the elevated levels toward normal. 
Similar large doses produced small decreases of catalase 
activity in normal animals•
Our work along these same lines is essentially in 
agreement with the findings of Gaebler and Mathies (1951)•
This study was done on three groups of male rats of the same 
age. Group 1 (Table IX) was maintained as controls, groups
2 and 3 were hypophysectomized when they were 55 days old.
Group 2 received no further treatment but group 3 received
0.4 mgm. of Armour*s growth hormone beginning 30 days after 
operation and continuing through the 107th day postoperativel.y;
24
I from then tintil autopsy, which was 1?0 days after hypophysecj- 
|tomy, these animals received 0.8 mgm. daily of growth hormonls.
I TABLE IX
I  EFFECT OF HIPOPHYSEGTOMT AND GROWTH HORMONE
ON LIVER CATALASE ACTIVITY IN MALE RATS
i Nur.ber Adrenal
IGroup Treatment Animals Weight Activity Range
1 CONTROLS 3 21.9 mg 755 (646-847)
2 HYPOPHYSEC­
TOMIZED 5 5.6 871 (772-971)
3 HYPOPHYSEC­
TOMIZED
plus 4 8.1 849 (707-949)GROWTH- 
HORMONE
Although it was felt that the groups in this series were too 
small to allow statistical analysis, it appears that hypo­
physe ctomy promoted an increase of catalase activity while 
replacement therapy with growth hormone, in the small doses 
used, did not cause an appreciable change.
Mechanism of Catalase Depression 
by Cortisone and Hydrocortisone 
Throughout this part of the study an explanation of 
the depressing effect of cortisone and hydrocortisone on 
catalase was being sought. Two lines of evidence persuaded 
us that the availability of iron for the synthesis of catalase, 
which by the work of Sumner and Bounce (1937) has been shown
25
to contain iron in its molecule, might be an important cog 
I  in the mechanism. First, Fukuoka and Nakahara (1951) have
reported that the depression of catalase by the fraction that
I  '  ■ ■ ■  ithey isolated from tumor tissue can be neutralized by the
-  ,
injection of iron salts. It appears, from this observation, 
jthat the tumor material might be producing its effects on liver 
I catalase by combining with iron and in some way removing it 
jfrom the circulation, thus limiting its availability for the 
synthesis of catalase.
Secondly, Hamilton, Gubler, Ashenbrucker, Cartwright 
and Wintrobe (1951) have shown that adreno-cortical extract 
or cortisone (4-8 mgm. ) produces acute hypoferremia in rats.
The hypothesis that cortisone may be depressing catalase by 
virtue of its hypoferremic action was tested by giving iron 
with cortisone to determine whether any reversal or lessening 
of the depression would result. Table X shows the findings 
of this procedure. The group of animals receiving both 
cortisone and iron were given ferrous sulfate^ intramuscularly 
in sufficient quantity to equal 1 mgm. of iron daily. This 
amount of ferrous sulfate was dissolved in 0.2 cc. of dis­
tilled water for injection. . The site of injection was 
alternated between the two heavy thigh muscles of the rats.
^Baker's Reagent grade ferrous sulfate. All animals 
in this study were fed Purina Dog Chow which contains approxi­
mately 32 mgm. of iron per 100 grams of feed.
26
TABLE X







Body Wt. Activity Range




6 15.0 -7 gm 501 (400-616)
CORTISONE 
(5mg/day: 





6 18.9 -57 435 (390-495)
The data in Table X confirm the marked depression of catalase 
by cortisone but there is no indication that the intramusculfr 
administration of iron salts prevents or lessens this process, 
rather the indication is that the iron injections produced a 
small additional depression.
Prevention of Cortisone-Induced Adrenal Atrophy 
During the attempt to determine whether or not plasma 
iron plays a role in the reduction of liver catalase activity 
caused by cortisone acetate, an interesting and unexpected 
influence on the adrenal glands was noted. As indicated in 
Table X, the administration of 5 mgm. of cortisone, acetate 
per day produced a very significant reduction in the weight 
of the adrenal glands. This reduction was expected and is
th
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anterior pituitary gland. When a similar group of animals 
(group 3, Table X) was given the same amount of cortisone 
and in addition 1 mgm. of iron intramuscularly, a striking 
reduction of the atrophy occurred. This observation was 
followed up with a number of experiments designed to clarify 
the mechanism through which the iron was acting to prevent 
the cortisone-induced adrenal atrophy. The data in Table XI
confirm the original observation, in that cortisone (group 2)
\reduced the adrenal weight and the addition of iron to the 
regimen (group 3) prevented the cortisone-induced adrenal 
atrophy. In fact, it is seen that when the adrenal weight 
is expressed on a body weight basis, to off-set the greater 
loss of weight in the animals receiving both cortisone and 
iron, the iron actually caused an adrenal hypertrophy even 
during cortisone administration. It is further noted (group 
4) that when iron was given alone, a marked increase in 
adrenal weight resulted.
Further, it was of interest to establish whether or 
not iron given orally would produce the same effect on the 
adrenal glands as when given intramuscularly. Table XII 
shows the results of this experiment. In this instance the 
iron was given by stomach tube and it is seen that the resul<s 
are, in general, the same as when iron was given intramuscu­
larly. Thus cortisone caused the usual atrophy; iron given 
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INFLUENCE OF IRON SALTS ADMINISTERED BY STOMACH INTUBATION 
ON CORTISONE-INDUCED ADRENAL ATROPHY
Number Body Weight Adrenal Weight
Group Animals Treatment Initial Final Absolute Relative*
1 6 CONTROLS 327 gm 320 gm 24.9 mg 15.6 mg
2 5 CORTISONE





plus 340 262 20.5 15.9
IRON (FeSOĵ )
(2 mg/day;
10 days in 
stomach)
4 4 IRON (FsSOa )
(2 mg/day; 36I 331 28.5 17.510 days in 
stomach)
* mgm of adrenal tissue per 100 gms of body weight.
so
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; iron given by itself produced adrenal hypertrophy. It must 
I be mentioned here that the values were more erratic in this 
I experiment than when the iron was given in the muscle, that
I is, the adrenal weights in groups 3 and 4 were spread over a
Iwider range. This may be a reflection of the variability in 
Iiron absorption by the gut of the individual animals.
I Up to this point, the iron compound used was ferrous
I sulfate but because this substance often produced a tissue
Ireaction at the site of injection a milder iron salt was |
sought. On the basis of the work of Reznikoff and Goebel j
(1937), ferrous gluconate^ was chosen and used throughout the 
remainder of this investigation. It was found to produce very 
little or no irritation at the site of injection and no appar­
ent discomfort to the animals following injection. The effects 
of this compound were studied in four groups of animals, as 
indicated in Table XIII. Here the same pattern is seen, i.e., 
ferrous gluconate tends to maintain the adrenal weight during 
cortisone administration and when ferrous gluconate is given 
alone adrenal hypertrophy results.
In view of the fact that iron causes adrenal enlarge­
ment to about the same extent as ACTH, it was of interest to 
determine whether iron would potentiate the action of ACTH.
In Table XIV it is seen that iron given concurrently with
^Courtesy of Dr. A. Scribner, Winthrop—Stearns Inc., 
New York City, New York.___________ ________________________
TABLE XIII
INFLUENCE OF IRON SALTS ON CORTISONE-INDUCED ADRENAL ATROPHY
Number Body Weight Adrenal Weight I
Group Animals Treatment Initial Final Absolute Relative I
1 4 DISTILLED H2O
(.2 cc/day; 197 gm. 203 gm 20.1 mg 19.8 mg
10 days I.M.)
2 4 CORTISONE
(3 mg/day; 192 162 14.6 17.9
10 days)









(1 mg/day; 192 180 23.4 26.2
10 days I.M.)
TABLE XIV 



























* mgm of adrenal tissue per 100 gm of body weight.
Adrenal Weight I 
Ab 8olut e Relative*'






ACTH (group 3) produces a greater enlargement of the gland 
than ACTH given alone (group 2). This difference is seen 
when the adrenal weights are expressed either as absolute 
values, i.e., mean weight for a single adrenal gland or as 
relative weights, i.e., mgm. of adrenal tissue per 100 grams 
of body weight. The increase in the relative weight in grou 
3 is somewhat out of proportion to the increase in absolute 
adrenal weight of this group. This is due to the loss of 
body weight suffered by the animals in group 3» These data 
then show that ferrous gluconate given intramuscularly in 
sufficient quantity to supply the equivalent of 1 mgm. of 
iron (8.3 mgm. of ferrous gluconate) will potentiate the 
"adrenal enlarging action" of ACTH.
Influence of Cortisone on Catalase Activity In Vitro
Having established that cortisone will inhibit catalas 
in vivo, it was decided to determine whether or not this 
inhibition would also occur in a homogenous ^  vitro system. 
This procedure should give some insight into the mechanism 
of inhibition in that if inhibition could be demonstrated 
in vitro it could be assumed that the steroid was probably 
combining in some fashion with the catalase molecule and this 
inhibiting its normal activity. The binding of certain 
.steroids to proteins has been demonstrated (Samuels, 1954)* 
This problem was approached in the following way: crystalline
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catalase-^ was obtained and preliminary experiments were 
carried out to determine what concentration of the enzyme 
would be the most convenient for the assay procedure. The 
I  crystalline catalase was placed in cold buffer, 1 mgm. perI - . . . . . . .
Icc., and the solution was centrifuged to remove insoluble 
material. A sample of the supernatant was then further 
diluted to give a final concentration of 0.5 mgm. of catalase 
per ml. of solution. One cc. samples of this solution were 
placed in two tubes, one of which contained 1 mgm. of cor­
tisone acetate in 0*4 cc. of saline. The other tube contain­
ing 0.4 cc. saline alone served as control. This mixture was 
incubated at 37 degrees C. for 30 minutes. Samples of 0.5 
cc. were then taken from each tube and assayed in the usual 
manner for catalase activity. This procedure was repeated 
with quantities of cortisone acetate ranging up to 25 mgm.
In no case was there a difference between the activity of the 
cortisone-catalase mixture and the control catalase solution 
indicating that in a homogenous cell free system such as thi^, 
cortisone does not inhibit catalase as it does in the intact 
animal. This is taken to mean that cortisone does not combine 
directly with the catalase molecule, at least in the absence 
of the intact cell. However, this observation in no way rulos 
out the possibility that cortisone could be shown to inhibit 
catalase activity in surviving tissue in vitro.
^Delta Chemical Company, New York, N.Y..
CHAPTER III 
DISCUSSION
This study and similar studies of other investigators 
indicate that the hormonal regulation of catalase activity 
is an extremely complex mechanism and that our knowledge of 
the subject is probably still insufficient to allow a precise 
description to be made. Nonetheless, it is interesting to 
speculate whether or not the various hormonal factors studied 
kave a common basis for their effect on liver catalase activ­
ity. One might assume that the adrenal corticoids are the 
primary hormonal entities influencing the action of this 
enzyme, since the corticoids produce the greatest effect seer, 
to date. On this assumption it follows that the increased 
activity seen after hypophysectomy might be due to a reduction 
of endogenous corticoid production. Another line of evidence 
that fits this hypothesis is the work of Begg, Dickinson and 
White (1953). They demonstrated a 20% reduction of liver 
catalase activity in male rats treated with the synthetic 
estrogen diethylstilbestrol. It is known that estrogen causes 
stimulation of the adrenal cortex via an increased release
of cbrticotropin by the anterior pituitary (Ingle, 1953)---
' 35
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In this indirect way the corticoids may also be causing the 
catalase depression seen in the estrogen treated animal. The 
lower catalase activity in females as compared to that of 
males might be explained in a similar manner and here it is 
well to note that the adrenal glands of the female rat are 
always larger than those of the male. Just as it is known 
that estrogens promote adrenal function, it is equally well 
known that testosterone causes a pronounced decrease in 
adrenal weight and presumably in adrenal function (Selye and 
Stone, 1 950). One might interpret this to be part of the 
mechanism responsible for a higher catalase activity in males 
than in females.
The observation, in our studies, that testosterone 
administered to mature female rats gives an indication of 
increased catalase activity can likewise be explained on this 
basis. Thus, when testosterone, which causes a decrease in 
adrenal function, is given to the mature female rat the out­
put of adrenocortical hormones is depressed resulting in an 
elevation of catalase activity. The fact that our data 
indicate only a slight increase of activity takes on fuller 
meaning when it is considered that the mature female animals 
receiving testosterone were simultaneously producing estroge.i 
which tends to increase adrenal function and thereby lower 
catalase activity.
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While the above discussion holds for the matu-rm f é 
rat, it was observed in Table 7 (p. 18) that although testos­
terone promoted an increase in catalase activity in the mature 
female (groups 2 and 4), similar treatment of immature animals 
(group 6) produced no change in enzyme"activity. It therefore 
appears that the immature female (producing no estrogen) 
responds to testosterone administration with regard to catalase 
activity in a different manner than does the mature animal.
Pursuing the hypothesis that the corticoids are the 
primary factor in catalase regulation, it might be supposed 
that castration in the male would decrease the catalase 
activity. There was some indication that this did occur.
It is interesting to note, in conjunction with the slight 
difference between the catalase activity of these groups 
(Table 71, p. 21) that the adrenal weights were unchanged.
If the above hypothesis of hormonal control of catalase 
activity is to hold it must also explain thé apparent parado3t 
bhat whereas exogenous cortisone and hydrocortisone cause a 
marked depression of liver catalase activity in the rat, 
administration of ACTH or adrenalectomy produce no observable 
change. This apparent inconsistency might be resolved by a 
consideration of the biochemical processes in adrenocortical 
secretion and the role that ACTH is thought to play in 
corticosteroidogenesis.
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j The ■well-established view that adrenal cholesterol is
a potential precursor of corticosteroid hormones plus the 
recognition that acetate is synthesized to cholesterol in 
the adrenal gland (Srere, Chaikoff and Dauben, 1948) have led 
to the extensive study of these two substances as corticos­
teroid precursors. For a time it was thought that acetate 
was converted to cholesterol as an obligatory intermediary 
(Hechter, Solomon, Zaffaroni and Pincus, 1953), which in turn 
was converted through a series of intermediates to hydrocorti­
sone and corticosterone. The recent studies of Stone and 
Hechter (1954) now make it seem more likely that acetate is 





With the knowledge that cholesterol is a major precursor and 
that hydrocortisone and corticosterone are the major end 
products of corticosteroid biosynthesis, Hechter, Pincus and 
their co-workers (see Hechter and Pincus, 1954) were able to 
formulate a reaction sequence for corticosteroid biosynthesis 
and to substantiate it by perfusion studies of the adrenal 
cortex. Figure 1 illustrates their scheme. The available 
evidence strongly indicates that ACTH enters into this 
-se que nee--between ch o 1 e s t e r o 1 -S-hd pregnen o 1 o nê  L
39
action stimulates the degradation of the cholesterol side 
chain.
p e e g n e n o l o n:
CHOLESTEROL
ACETATE




REACTION SEQUENCE OF CORTICOSTEROID BIOSYNTHESIS 
(after Hechter and Pincus)
The postulated alternative pathway of acetate conversion to 
corticoid, which does not involve acetate conversion to 
cholesterol, is not significantly increased by ACTH. The 
suggestion from these experiments is that corticoid synthesi 
in the absence of ACTH, may proceed primarily from acetate 
through the noncholesterol pathway. When ACTH is present, 
the cholesterol pathway is utilized as well.
As already mentioned, in all species studied one or 
two corticosteroids are regularly found in highest concen­
tration in the adrenocortical secretion: hydrocortisone and
corticosterone. However, the relative proportions of these 
compounds are markedly different in various species but the
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ratio is fairly constant within a species (Bush, 1953).
The characteristic ratios of the two major components 
of the adrenalcortical secretion (hydrocortisone: corticos­
terone) are apparently influenced by a number of factors. 
iThus, while acute ACTH treatment does not appreciably alter 
the characteristic ratio, chronic treatment profoundly modi­
fies the corticosteroid pattern (Kass, 1954). Kass feels that 
in addition to its acute direct action in corticosteroido­
genesis, ACTH alters the pattern of corticosteroid formed by 
Iinfluencing the synthesis of enzymes involved in corticos- j
jteroidogenesis.
I Although cortisone and hydrocortisone depress catalas< 
activity, neither ACTH nor adrenalectomy influence this enzyme. 
This apparent inconsistency may, perhaps, be resolved in the| 
light of the foregoing discussion. It is clear that the
genesis of the adrenocortical secretion is a very complex and
 ̂ ■ ' ' ■ ! labile mechanism and that the ratio of the active corticoids!
may well play a significant role in the biochemical response!Ito this secretion. It is felt then that the best explanation
at the present time for the lack of a.n effect with ACTH on
catalase activity lies in the concept of relative proportions
of the corticoids. This explanation is admittedly specula- |
! I
tive, and other theories will have to be considered as new |
evidence is found. This concept of hormonal balance as an
‘ïS^ortant^âctor xh the~infruence-of- hormone-s-on--enzy^
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not without precedence. The hormonal regulation of the 
enzyme hexokinase is a classical example. Insulin on the 
one hand and growth hormone and 11-oxycorticosteroids on the 
other have a competitive action on this enzyme, the latter 
inhibiting the reaction catalyzed by hexokinase and the 
former overcoming this inhibition. Evidence is accumulating; 
to indicate that the control of hexokinase activity is pri- ! 
marily dependent on the ratio of pituitary-adrenal to insulin 
■activity, rather than on 'the absolute amounts of either i
jhormone. In the absence of all three, carbohydrate utiliza-l
!  .  , I
jtion (as an index of hexokinase activity) may be almost j
I '  IInormal (Engel, 1954). This normalcy of enzyme function in
the absence of the competitive forces may be the reason our 
experiments failed to show any change in catalase activity
: Iafter adrenalectomy. j
One other point that fits the concept that the adrenop
I  ■  -  •  . . .  Ij Icortical secretion may be the principal hormonal factor in 
catalase regulation is the observation by Begg (1951) that 
together with the decreased liver catalase level in cancerous 
animals there is an enlargement of the adrenal glands with
loss of ascorbic acid and cholesterol.
Other investigators have studied hormonal influences 
ion catalase activity. Begg (1953) using the rat as experi- 
imental animal showed that while cortisone in doses of 1-3 mgm.
Îper ' d a y  “wii‘l'~ de press the- liver cat ala se act i-vi-ty,— adrenalectomy
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has no effect on this liver enzyme « These observations are 
in agreement with our earlier findings. There appears to be 
a species difference in catalase activity between the rat 
and mouse. Adrenalectomy in the mouse results in a depres­
sion in liver catalase activity, (Adams, 1952). Cortisone 
will restore the normal level. Adams further reports that 
the catalase activity in females is lower than in males and 
that the level in females can be elevated to that of the mal 
by testosterone administration. Castration of adult male 
mice also produces a depression of enzyme activity that can 
be normalized by testosterone injections. There is precedent 
for opposite effects in enzyme concentration in different 
species after the administration of the same hormone, Testojs 
terone causes quite different effects on kidney alkaline | 
phosphatase in the rat and mouse, (Kochakian, 1947).
jPrevention of Cortisone-Induced Adrenal Atrophy 
It is felt that two possible explanations can be givep 
for the prevention of cortisone-induced adrenal atrophy by : 
iron salts. First, it is known that any type of stress pro-: 
duces an increase in weight of the adrenals, and it is i
■ ■  ■ ■  '  ■  ^  I
believed that the weight response in such conditions is an 
aspect of the adaptation of the adrenals to the increased 
requirement for cortical hormones by the body (Selye, 1937) 
(Ingle, 193S, 1939); in other words, the gain in adrenal
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weight. Tinder conditions of stress, is considered to be due 
to an hypertrophy of the cortex with a corresponding increase 
in adrenal cortical hormone production, and consequently an 
increased resistance towards the damaging agent. In view of 
this concept it might be argued that the intramuscular 
administration of iron exerts the observed effect on adrenal 
weight simply by acting as a non-specific stress because thils 
procedure does evoke some discomfort in the animals. We do 
not feel, however, that this accounts for the total degree 
of adrenal hypertrophy that is seen. It has been shown by 
many authors that the enlargement of the adrenal cortex in 
animals under stress can be prevented ('Ingle, 1938) (Selye, 
1940). It may even become atrophied (Selye and Dosne, 1942) 
when the animals under stress are treated with sufficiently 
high doses of adrenal cortical hormones. Since the animals 
in this study were receiving relatively high doses of cor­
tisone (3-5 mgm.) it is very unlikely that the mild stress 
associated with the injection of the iron was responsible
for the adrenal hypertrophy.
Second, it may be that iron plays a heretofore unsus­
pected role in the function of the adrenal cortex; perhaps 
as an integral part of some enzyme system of this gland.
There is no direct evidence that this is the case, but two 
studies point indirectly to this possibility:
___ 1-. Hamilton.,_ .et_.al., ̂ (I951I have _eŝ tab]J,shed̂ t̂  ̂ ----
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adrenal cortex plays an essential role in the main­
tenance of the normal homeostasis of the plasma iron 
level. Adrenalectomy resulted in a decrease in the 
level of the plasma iron of rats. This decrease was 
prevented by administration of small doses of adreno­
cortical extract or cortisone but not desoxycorti- 
costerone. Larger doses of adrenocortical extract, 
cortisone or ACTH produced acute hypoferremia in 
intact rats,
2. Keston, (1954) using an in vitro system containing 
ascorbic acid, ferrous sulfate, and steroid in an 
atmosphere of oxygen have shown that this system will 
promote the introduction of hydroxyl groups into 
adrenal steroids. The possibility therefore exists 
that ferrous ions are a necessary component of the 
enzyme systems that bring about the physiological 
production of the hydroxycorticoids.
It is felt that the indications from these morphologi 
cal studies of the adrenal glands are sufficiently suggestiv 
of an important role of iron in adrenal metabolism that test 
should now be conducted to assess the functional capacity of 
the adrenals of animals treated with iron.
Although cortisone has proven to be useful in a varie
of clinical conditions, it exerts certain hormonal effects 
which do not contribute to its therapeutic value and which.
ty
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indeed, it would be desirable to avoid if possible. Among 
these is adrenal atrophy. Much work has been done recently 
to determine whether one or more of these unwanted effects 
could be counteracted without, diminishing the desired actions 
of the hormone; the usefulness of cortisone would then be 
enhanced. The growth-inhibition and other toxic manifesta­
tions of cortisone or ACTH have been in part antagonized by 
a variety of means such as liver therapy (Ershoff, 1951), 
aureomycin (Meites, 1952), potassium (Whitney and Bennett, 
1952) and fat (Kinsell, Olson, Boling, Partridge and Margen, 
1951). The adrenal atrophy which occurs when cortisone is 
given has been prevented by steroids such as methylandros- 
tenediol and testosterone propionate (Winter, Boilings and 
Stebbins, 1953) (Gaunt, Tuthill, Antonchak and Leathern, 1953)
In the face of these studies, a question of paramount 
interest concerns the functional capacity of the adrenal gland 
maintained with iron compounds in the presence of treatment 
with cortisone. If the functional capacity of the adrenal 
gland, in this condition, does remain normal the therapeutic 
applicability of this finding would be overshadowed only 




1. The influence of numerous hormonal factors on the 
liver catalase activity of the rat has been studied. This 
was accomplished either by administering the active material 
to the animals or by surgical removal of certain endocrine 
glands. The hormonal control of catalase activity is regard,ed 
as one facet of the larger concept that hormones may be exert­
ing their influence in the living organism by regulating the 
activity of enzymes.
2. Cortisone acetate, administered in amounts ranging 
from 2 to 10 mgm. daily, was found to produce a marked reduc 
tion of liver catalase activity.
3. Contrary to expectations, adrenocorticotropic 
hormone did not alter the liver catalase activity, even in 
doses of 6 mgm. per day.
4. A sex difference in liver catalase activity was 
noted. The activity in the male was approximately 2$$ greater 
than the corresponding activity of the female. This finding 
confirms the work of Schultze and Kuiken (1941) which also 
-demonstrated—a-higher— catalase-activity—m —the—male— rat_than
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in the female rat.
5» Testosterone promoted an increase of catalase 
activity in mature female rats but not in immature females„ 
Possible reasons for this difference in response to testos­
terone were discussed.
6. Castration of male rats did not alter the catalas; 
activity to a degree that was statistically significant. 
However, a slight depression of the enzyme activity was 
indicated.
7» Young adrenalectomized male rats, maintained for 
12 days on sodium chloride, did not show a liver catalase 
activity different from the activity of normal control animals.
8. Hydrocortisone, administered by intragastric intu­
bation, in quantities of 5 mgm. daily produced a decrease in 
liver catalase activity comparable to the decrease seen after 
similar quantities of cortisone,
9. The hypothesis that cortisone depresses catalase 
activity by virtue of its hypoferremic action could not be 
supported by experimental findings,
10. Cortisone did not suppress catalase activity in
an ^  vitro system,
11* A tentative hypothesis of hormonal control of 
catalase activity is proposed. This hypothesis takes the 
findings of this and similar studies into consideration.
-I-t_i s-base d_on_the_ c once pt that t h e a dr en q c or t i c al s e_cr^i oh s
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are the principal hormonal factors in catalase regulation.
The changes in enzymatic activity seen after other endocrine 
changes are, according to this hypothesis, due to simultaneous 
quantitative or qualitative changes in adrenocortical secre­
tion,
12, It has been demonstrated in this study that the 
adrenal atrophy that occurs in rats treated with cortisone 
can be prevented by the simultaneous administration of iron 
salts either intramuscularly or orally. It has been further 
demonstrated that iron salts will potentiate the "adrenal- 
enlarging action" of adrenocorticotropic hormone.
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